{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:24Z","timestamp":1791859044369,"version":"4.3.4"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100001296","name":"PKD foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001296","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Univ. of Kansas Medical Center"},{"name":"ADPKD"},{"name":"NHK"},{"name":"NYUCI Center Support"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","award":["5 P30CA16087"],"award-info":[{"award-number":["5 P30CA16087"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Experimental Pathology Research Laboratory"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1093\/ndt\/gfx349","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T23:12:17Z","timestamp":1512601937000},"page":"1343-1353","source":"Crossref","is-referenced-by-count":37,"title":["Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease"],"prefix":"10.1093","volume":"33","author":[{"given":"Irfana","family":"Soomro","sequence":"first","affiliation":[{"name":"Division of Nephrology, New York University Langone Medical Center, New York, NY, USA"},{"name":"The Helen L. and Martin S. Kimmel Center for Biology and Medicine, New York University Langone Medical Center, New York, NY, USA"},{"name":"Skirball Institute for Biomolecular Medicine, New York University Langone Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[{"name":"Division of Nephrology, New York University Langone Medical Center, New York, NY, USA"},{"name":"The Helen L. and Martin S. Kimmel Center for Biology and Medicine, New York University Langone Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhai","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Nephrology, New York University Langone Medical Center, New York, NY, USA"},{"name":"The Helen L. and Martin S. Kimmel Center for Biology and Medicine, New York University Langone Medical Center, New York, NY, USA"},{"name":"Skirball Institute for Biomolecular Medicine, New York University Langone Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonnette","family":"Diggs","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Hatzivassiliou","sequence":"additional","affiliation":[{"name":"Cancer Immunology, Genentech, South San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit G","family":"Thomas","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Rais","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara S","family":"Slusher","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Somlo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Yale University School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Y","family":"Skolnik","sequence":"additional","affiliation":[{"name":"Division of Nephrology, New York University Langone Medical Center, New York, NY, USA"},{"name":"The Helen L. and Martin S. Kimmel Center for Biology and Medicine, New York University Langone Medical Center, New York, NY, USA"},{"name":"Department of Biochemistry, New York University Langone Medical Center, New York, NY, USA"},{"name":"Department of Molecular Pharmacology and Molecular Pathogenesis, New York University Langone Medical Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"key\n\t\t\t\t20180801035957_gfx349-B1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2215\/CJN.00060108","article-title":"Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies","volume":"3","author":"Chapman","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/j.ackd.2010.01.006","article-title":"Treatment strategies and clinical trial design in ADPKD","volume":"17","author":"Torres","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B3","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B5","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1111\/j.1742-4658.2012.08651.x","article-title":"Normal and cancer cell metabolism: lymphocytes and lymphoma","volume":"279","author":"Altman","year":"2012","journal-title":"FEBS J"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cmet.2011.07.014","article-title":"Metabolic flux and the regulation of mammalian cell growth","volume":"14","author":"Locasale","year":"2011","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B8","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1681\/ASN.2015030231","article-title":"2-deoxy-d-glucose ameliorates PKD progression","volume":"27","author":"Chiaravalli","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B9","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","article-title":"Targeting mitochondrial glutaminase activity inhibits oncogenic transformation","volume":"18","author":"Wang","year":"2010","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.cell.2012.02.032","article-title":"Cellular metabolism and disease: what do metabolic outliers teach us?","volume":"148","author":"DeBerardinis","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem Sci"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s003350010190","article-title":"Identification of two human glutaminase loci and tissue-specific expression of the two related genes","volume":"11","author":"Aledo","year":"2000","journal-title":"Mamm Genome"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B14","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.biocel.2009.03.003","article-title":"Glutamine homeostasis and mitochondrial dynamics","volume":"41","author":"Mates","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2174\/1566524011313040005","article-title":"Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer","volume":"13","author":"Mates","year":"2013","journal-title":"Curr Mol Med"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B16","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1535-7163.MCT-13-0870","article-title":"Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer","volume":"13","author":"Gross","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.4161\/cbt.21348","article-title":"Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth","volume":"13","author":"van den Heuvel","year":"2012","journal-title":"Cancer Biol Ther"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molmed.2012.10.011","article-title":"Rho GTPases and their roles in cancer metabolism","volume":"19","author":"Wilson","year":"2013","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd3504","article-title":"Targeting cancer metabolism: a therapeutic window opens","volume":"10","author":"Vander Heiden","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B20","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","article-title":"Targeting glutaminolysis has anti-leukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition","volume":"126","author":"Jacque","year":"2015","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B21","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1172\/JCI75836","article-title":"Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis","volume":"125","author":"Xiang","year":"2015","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B22","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1021\/bi201613d","article-title":"Full-length human glutaminase in complex with an allosteric inhibitor","volume":"50","author":"DeLaBarre","year":"2011","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/BJ20070039","article-title":"Novel mechanism of inhibition of rat kidney-type glutaminase by bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl)ethyl sulfide (BPTES)","volume":"406","author":"Robinson","year":"2007","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B25","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","article-title":"Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys","volume":"63","author":"Yamaguchi","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B26","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ki.2008.246","article-title":"KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease","volume":"74","author":"Albaqumi","year":"2008","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B28","doi-asserted-by":"crossref","first-page":"10765","DOI":"10.1073\/pnas.1301693110","article-title":"miR-17\u223c92 miRNA cluster promotes kidney cyst growth in polycystic kidney disease","volume":"110","author":"Patel","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B29","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1128\/MCB.00019-12","article-title":"3-kinase C2beta and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells","volume":"32","author":"Srivastava","year":"2012","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B30","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.4161\/cc.22632","article-title":"Glutaminolysis feeds mTORC1","volume":"11","author":"Duran","year":"2012","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/ncpneph0070","article-title":"Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases","volume":"2","author":"Torres","year":"2006","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","article-title":"Fatty acid oxidation is impaired in an orthologous mouse model of autosomal dominant polycystic kidney disease","volume":"5","author":"Menezes","year":"2016","journal-title":"EBioMedicine"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B33","doi-asserted-by":"crossref","first-page":"14395","DOI":"10.1038\/ncomms14395","article-title":"microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism","volume":"8","author":"Hajarnis","year":"2017","journal-title":"Nat Comms"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B34","doi-asserted-by":"crossref","first-page":"e115144","DOI":"10.1371\/journal.pone.0115144","article-title":"Mesenchymal phenotype predisposes lung cancer cells to impaired proliferation and redox stress in response to glutaminase inhibition","volume":"9","author":"Ulanet","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI72873","article-title":"Pyruvate carboxylase is critical for non-small-cell lung cancer proliferation","volume":"125","author":"Sellers","year":"2015","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","article-title":"Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target","volume":"24","author":"Timmerman","year":"2013","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","article-title":"Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells","volume":"15","author":"Le","year":"2012","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B38","volume-title":"Polycystic Kidney Disease","author":"Trudel","year":"2015"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B40","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tibs.2015.01.004","article-title":"Famine versus feast: understanding the metabolism of tumors in vivo","volume":"40","author":"Mayers","year":"2015","journal-title":"Trends Biochem Sci"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B41","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/ndt\/gft521","article-title":"Defective metabolism in polycystic kidney disease: potential for therapy and open questions","volume":"29","author":"Rowe","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.celrep.2016.12.061","article-title":"Targeted inhibition of EGFR and glutaminase induces metabolic crisis in EGFR mutant lung cancer","volume":"18","author":"Momcilovic","year":"2017","journal-title":"Cell Rep"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B43","doi-asserted-by":"crossref","first-page":"F492","DOI":"10.1152\/ajprenal.00238.2015","article-title":"The cpk model of recessive PKD shows glutamine dependence associated with the production of the oncometabolite 2-hydroxyglutarate","volume":"309","author":"Hwang","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B45","doi-asserted-by":"crossref","first-page":"15965","DOI":"10.1038\/ncomms15965","article-title":"Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism","volume":"8","author":"Biancur","year":"2017","journal-title":"Nat Comms"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B46","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc.2016.114","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/jbiol63","article-title":"Metabolic reconfiguration is a regulated response to oxidative stress","volume":"7","author":"Grant","year":"2008","journal-title":"J Biol"},{"key":"key\n\t\t\t\t20180801035957_gfx349-B48","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1091\/mbc.e16-08-0597","article-title":"The polycystins are modulated by cellular oxygen-sensing pathways and regulate mitochondrial function","volume":"28","author":"Padovano","year":"2017","journal-title":"Mol Biol Cell"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/33\/8\/1343\/25198403\/gfx349.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T12:20:17Z","timestamp":1570450817000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/33\/8\/1343\/4840183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,2,5]]},"published-print":{"date-parts":[[2018,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfx349","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,2,5]]}}}